SCHEMBL8024086

SCHEMBL8024086

Cc1cccc(-c2nc3ccc(OCCN(C)C)cc3n2Cc2ccccc2C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.43
DRD3 P35462 3/20 0.43
TP53 P04637 4/20 0.42
UTS2R Q9UKP6 1/20 0.40
MAPT P10636 1/20 0.39
TNK2 Q07912 1/20 0.39
MDM2 Q00987 1/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ACHE P22303 1/20 0.39
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
ALOX5AP P20292 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
ACSS2 Q9NR19 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8025592 0.96 DRD2 (0.48) DRD2DRD3TP53MAPTMDM2
SCHEMBL8027466 0.91 MDM2 (0.41) DRD2DRD3TP53MAPTMDM2
SCHEMBL8027290 0.90 DRD2 (0.44) DRD2DRD3UTS2RTNK2TDP1
SCHEMBL8011200 0.86 DRD2 (0.45) DRD2DRD3TP53MAPTTNK2
SCHEMBL8023867 0.86 DRD2 (0.41) DRD2DRD3UTS2RTDP1ALOX5AP
SCHEMBL8027486 0.86 DRD3 (0.50) DRD2DRD3TDP1FGFR1SRC
SCHEMBL8011132 0.84 ESR1 (0.55) DRD2DRD3ESR1ACHE
SCHEMBL8025194 0.84 MDM2 (0.43) TP53MAPTMDM2TDP1ALOX5AP
SCHEMBL8021817 0.84 TP53 (0.61) DRD2DRD3TP53MAPTESR1
SCHEMBL8023740 0.82 DRD2 (0.46) DRD2DRD3FGFR1SRCTLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030992-A ANTAGONISTS FOR THE BINDING OF NEUROKININ-2 RECEPTOR; SLEEP DISORDERS; BENZIMIDES, 2- OR 3-ALKOXYBENZIMIDES AND 2,3-DIALKOXYBENZIMIDES ELI LILLY AND COMPANY (US) 2000-02-29 US claimed
US-6025379-A A SUBSTITUTED BENZIMIDAZOLE, TACHYKININ RECEPTOR ANTAGONISTS, ELI LILLY AND COMPANY (US) 2000-02-15 US claimed
EP-0694535-A1 Non-peptidyl tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-01-31 EP claimed
US-6030992-A ANTAGONISTS FOR THE BINDING OF NEUROKININ-2 RECEPTOR; SLEEP DISORDERS; BENZIMIDES, 2- OR 3-ALKOXYBENZIMIDES AND 2,3-DIALKOXYBENZIMIDES ELI LILLY AND COMPANY (US) 2000-02-29 US disclosed
US-6025379-A A SUBSTITUTED BENZIMIDAZOLE, TACHYKININ RECEPTOR ANTAGONISTS, ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed
US-5552426-A NERVOUS SYSTEM DISORDERS USING IMIDAZOLE DERIVITIVES ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0694535-A1 Non-peptidyl tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-01-31 EP disclosed